Institute for Neurodegenerative Disorders (IND)

New Haven, Connecticut 06510

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early